| 产品名称： | Human rhinovirus 15 |
|---|---|
| 商品货号： | TS165830 |
| Classification： | Picornaviridae, Rhinovirus |
| Agent： | Human rhinovirus 15 |
| Strain： | 1734 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | This product is a mycoplasma free preparation derived from VR-285. It replaces ATCC VR-1125 and ATCC VR-285, which will be discontinued when inventory is depleted. Strain 1734 is the prototype strain for human rhinovirus 15 and it has been fully sequenced (GenBank: DQ473493). |
| Product Format： | frozen |
| Storage Conditions： | xa0Store at -70°C or colder |
| Genome Sequenced Strain： | Yes |
| Comments： | This product is a mycoplasma free preparation derived from VR-285. It replaces ATCC VR-1125 and ATCC VR-285, which will be discontinued when inventory is depleted. Strain 1734 is the prototype strain for human rhinovirus 15 and it has been fully sequenced (GenBank: DQ473493). |
| Effect on Host： | Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells. Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells. |
| Growth Medium： | ATCC® Medium 30-2003: Eagles Minimum Essential Medium (EMEM) Fetal Bovine Serum |
| Recommended Host： | Production Host:H1-HeLa (ATCC CRL-1958) Production Host: xa0H1-HeLa (ATCC® CRL-1958x99) Alternate Hosts:WI-38 (ATCC CCL-75 ), HeLa (ATCC CCL-2 ), KB (ATCC CCL-17 ) and other human cells. |
| Growth Conditions： | For best results, plate cells 24-48 hours in advance. Infect at 80%-90% confluence using a multiplicity of infection (MOI) of 0.01 to 1.0. Incubate at 33.0°C in a humidified, 5% CO2 atmosphere for 2-7 days with rocking, until CPE are well advanced in 100% of the culture. Harvest cells and culture fluids; cell debris can be removed by centrifugation if desired. Freeze preparation as rapidly as possible. |
| Name of Depositor： | KM Johnson, RM Conant, VV Hamparian |
| Source： | Presumed from throat swab from young adult with upper respiratory illness, South Carolina, 1960; this preparation derived from ATCC VR-285 following treatment to remove mycoplasma. |
| References： | Fenters JD, et al. Propagation of Rhinovirus on WI-38 cell monolayers in rolling bottles. Appl. Microbiol. 15: 1460-1464, 1967. Kistler AL, et al. Genome-wide diversity and selective pressure in the human rhinovirus. Virol. J. 4: 40, 2007. PubMed: 17477878 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Human rhinovirus 15 |
|---|---|
| 商品货号： | TS165830 |
| Classification： | Picornaviridae, Rhinovirus |
| Agent： | Human rhinovirus 15 |
| Strain： | 1734 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | This product is a mycoplasma free preparation derived from VR-285. It replaces ATCC VR-1125 and ATCC VR-285, which will be discontinued when inventory is depleted. Strain 1734 is the prototype strain for human rhinovirus 15 and it has been fully sequenced (GenBank: DQ473493). |
| Product Format： | frozen |
| Storage Conditions： | xa0Store at -70°C or colder |
| Genome Sequenced Strain： | Yes |
| Comments： | This product is a mycoplasma free preparation derived from VR-285. It replaces ATCC VR-1125 and ATCC VR-285, which will be discontinued when inventory is depleted. Strain 1734 is the prototype strain for human rhinovirus 15 and it has been fully sequenced (GenBank: DQ473493). |
| Effect on Host： | Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells. Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells. |
| Growth Medium： | ATCC® Medium 30-2003: Eagles Minimum Essential Medium (EMEM) Fetal Bovine Serum |
| Recommended Host： | Production Host:H1-HeLa (ATCC CRL-1958) Production Host: xa0H1-HeLa (ATCC® CRL-1958x99) Alternate Hosts:WI-38 (ATCC CCL-75 ), HeLa (ATCC CCL-2 ), KB (ATCC CCL-17 ) and other human cells. |
| Growth Conditions： | For best results, plate cells 24-48 hours in advance. Infect at 80%-90% confluence using a multiplicity of infection (MOI) of 0.01 to 1.0. Incubate at 33.0°C in a humidified, 5% CO2 atmosphere for 2-7 days with rocking, until CPE are well advanced in 100% of the culture. Harvest cells and culture fluids; cell debris can be removed by centrifugation if desired. Freeze preparation as rapidly as possible. |
| Name of Depositor： | KM Johnson, RM Conant, VV Hamparian |
| Source： | Presumed from throat swab from young adult with upper respiratory illness, South Carolina, 1960; this preparation derived from ATCC VR-285 following treatment to remove mycoplasma. |
| References： | Fenters JD, et al. Propagation of Rhinovirus on WI-38 cell monolayers in rolling bottles. Appl. Microbiol. 15: 1460-1464, 1967. Kistler AL, et al. Genome-wide diversity and selective pressure in the human rhinovirus. Virol. J. 4: 40, 2007. PubMed: 17477878 |
